Greenlane announces exclusive distribution agreement with safety strips tech corp fentanyl, xylazine and drink spike detection test strips

Portfolio includes safety strips tech corp.'s low-cost test strip that provides an affordable, reliable way for people to test substances for two of the dangerous adulterants that are exacerbating the growing opioid epidemic greenlane to benefit from favorable inventory terms while leveraging its strong distribution, operations, marketing and sales teams to support the brand addition of high margin test strips enhances the company's portfolio of product offerings and revenue potential preparations underway for university and government opportunities boca raton, fl / accesswire / november 7, 2024 / greenlane holdings, inc. ("greenlane" or the "company") (nasdaq:gnln), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced an exclusive multi-year distribution agreement with safety strips tech corp ("safety strips"). under the agreement, greenlane will exclusively distribute safety strips fentanyl, xylazine and drink spike detection test strips in the u.s. safety strips, inc. testing strips "entering this adjacent product category has been high on our strategic priority list due to the alarming fact that the opioid crisis shows no signs of slowing and our customers are seeing increasing demand for more quality, affordable test strip options.
GNLN Ratings Summary
GNLN Quant Ranking